Moderators and speakers of the 10th AMR Conference
Adnaan Ghanchi
Co-Director, ARMoR (The Alliance for Reducing Microbial Resistance)
Benoît Hennion
Co-Founder & Co-CEO, Tamrisa
Betsy Wonderly Trainor
Alliance Director Diagnostics, CARB-X
Cameron Ball
Co-Founder and Chief Technology Officer, Scout Health
Carmen Coxon
Regulatory Scientist, UK Medicines and Healthcare Products Regulatory Agency (MHRA)
César de la Fuente
Presidential Associate Professor, University of Pennsylvania
Christoph Dehio
Professor of Molecular Microbiology at Biozentrum, University of Basel, and Director of the NCCR AntiResist
Christopher Lim
Chief, PAHO Strategic Fund
Claude Mabilat
Director Medical Value AMR/AMS, bioMérieux
David Paterson
Professor ADVANCE-ID, National University of Singapore
Deepali Patel
Director of international policy, AMR Action Fund
Delphine Croisier
CEO, VIVEXIA
Eric van der Helm
Head of Business Development, SNIPR Biome
Evan Loh
CEO, Paratek Pharmaceuticals
Florence Séjourné
CEO, AUROBAC THERAPEUTICS & Board Member and Founder, BEAM Alliance
Guillermo Tramontin
Associate Partner, Cavenagh Health
Hee-Jong (Jason) Hwang
CEO, A&J Science
Helerin Eiche
Quality assessor for biologics, State Agency of Medicines (Estonia)
Jan Rybniker
Professor and Head of Infectious Diseases, University Hospital Cologne
Jinyan Liu
Senior RA Director, Hangzhou Tigermed Consulting Co., Ltd.
John Rex
Chief Medical Officer, F2G Ltd. & Operating Partner, Advent Life Sciences
Kevin Lamkiewicz
Team-Lead DataScience and AI, SMA Development GmbH
Kevin Outterson
Austin B Fletcher Professor, Boston University, and Executive Director & Principal Investigator, CARB-X
Kristof Van Emelen
CEO, Obulytix
Laura Alonso Irujo
EU-JAMRAI 2 Communication Coordinator, Spanish Agency of Medicines and Medical Devices
Lauriane Cabon
Group Lead at the Institute of Human Biology, F. Hoffmann-La Roche
Leela Maitreyi
Director Business Development, Strategy and Global Collaborations, Bugworks Research
Lucas Boeck
Consultant Pulmonary Medicine, University Hospital Basel
Marc Gitzinger
CEO, BioVersys AG & President, BEAM Alliance
Marc Lemonnier
CEO, Antabio SAS
Marco Caproni
Global Director for Software Product Assessment, TÜV SÜD
Mark Beards
CEO, Santero Therapeutics
Marta Vieira
Chief Operating Officer, Immunethep
Martin Everett
CSO, AUROBAC THERAPEUTICS
Michael Lobritz
Global Head of the Infectious Diseases Therapeutic Area, F. Hoffmann-La Roche Ltd
Mihai Rotaru
Director Market Access, EFPIA
Morgane Vanbiervliet
Director, Global Business Development & Licensing, Debiopharm International SA
Neha Prasad
Senior Manager, Rubrum Advising
Nicola Ivan Lorè
Project Leader, Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute
Nina Khanna
Head Division of Infectious Diseases, University Hospital Basel
Patricia Martin
Chief Operating Officer, LimmaTech Biologics AG
Peter Seiler
Member of the management team, INCATE
Rachel Freeman
Principal, Antimicrobial Resistance, IQVIA
Radu Botgros
Senior Scientific Officer, European Medicines Agency
Richard Alm
Chief Scientific Officer, CARB-X
Rienk Pypstra
Chief Medical Officer & Head of Infectious Diseases, tranScrip
Robert Kimbui
SECURE Project Lead for the Global Access Team, Global Antibiotic Research & Development Partnership (GARDP)
Romney Humphries
Director Infectious Diseases Laboratories, Vanderbilt University Medical Center
Subhendu Basu
CEO & Board member, Telum Therapeutics
Suzanne Edwards
Incentives Workstream Lead & Advisor, Global AMR R&D Hub
Valeria Gigante
AMR R&D Lead, World Health Organization
Yann Ferrisse
Director, Business Development & Partner Engagement, Global Access at Global Antibiotic R&D Partnership (GARDP)
Yeung-Hyen Kim
Director, Lifetech Institute, iNtRON Biotechnology, Inc.
Yonghong Xiao
Vice-director State Key Laboratory of Diagnosis & Treatment of Infectious Diseases, Zhejiang University
York Zöllner
Professor of Health Economics at Hamburg University of Applied Sciences